Press Release

Nobias Therapeutics Announces Strategic Focus and New Leadership

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at UBS Global Healthcare Conference

Study PRO-101: Experience implementing an ALS community advisory board in early phase drug development

Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences

Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease

ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting

Aspen Neuroscience: Study of ANPD001 Autologous Neuronal Cell Replacement Treatment Approach Published in Journal of Neurosurgery